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Viruses infect the majority of eukaryotic life on the planet and remain a global threat to 
human health. These pathogens are constrained to intracellular life cycles, as they exploit and 
rely on host factors and machinery throughout their entire reproduction process. While many of 
these viral life cycle factors have been reported and studied, our knowledge in the identity and 
function of these factors remains incomplete and a challenge in fundamental virology and the 
development of antiviral therapeutics. Caenorhabditis elegans offers an innovative approach for 
discovering novel host factors required for virus infection in a multicellular and simple model 
organism. Although C. elegans has been extensively used as a model to study bacterial and 
fungal infections, viral studies have been highly restricted due to the lack of a naturally infecting 
C. elegans virus. Therefore, the discovery of Orsay virus as the first natural viral pathogen of C. 
elegans presents an unprecedented opportunity to advance our understanding of vital virus 
x 
 
interactions with its host. As many C. elegans genes are evolutionarily conserved in higher 
organisms, pro-viral factors in C. elegans may have a conserved function in humans for 
pathogenic viruses. Thus, the study of the C. elegans-Orsay virus model may ultimately lead to 
the development of antiviral therapeutics. In this dissertation, I exploit the power of this nascent 
C. elegans-Orsay virus system to identify and characterize two novel host factors that Orsay 
virus relies upon for infection, one of which was also found to play an evolutionarily conserved 
pro-viral role in human cells.       
First, I identified the C. elegans protein dietary restriction-like 1(DRL-1) as a novel host 
factor required for Orsay virus infection. Through a chemical mutagenesis screen, based on a 
virus-inducible green fluorescent protein (GFP) transcriptional reporter, I isolated a C. elegans 
mutant lacking a functional drl-1 gene. This drl-1 mutant demonstrated a greater than 10,000-
fold reduction in Orsay virus RNA levels, which could be rescued by ectopic expression of wild-
type DRL-1. Additionally, DRL-1 was dispensable for Orsay RNA replication from an 
endogenous transgene replicon, suggesting that DRL-1 affects a pre-replication stage of the 
Orsay life cycle. As drl-1 encodes a putative serine-threonine kinase that shares similarity with 
human mitogen activated protein kinases (MAPK), it implicates for the first time in C. elegans, a 
role for a MAPK pathway in viral infection.  
Second, as the chemical mutagenesis aforementioned was not saturated, I expanded this 
forward genetic screen, and identified the C. elegans protein huntingtin-interacting protein 
related 1 (HIPR-1) as another novel host factor required for Orsay virus infection. HIPR-1 
belongs to the Huntingtin-interacting protein family, whose members are known to be key 
factors in clathrin-mediated endocytosis through inositol phospholipid, clathrin light and heavy 
chain, and F-actin binding. Ablation of HIPR-1 in C. elegans also resulted in a significant defect 
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in viral RNA replication, a defect which could be bypassed through an endogenous transgene 
replicon system, suggesting a lack of HIPR-1 also affects an early, pre-replication step of the 
virus life cycle stage.  
To characterize the functional nature of HIPR-1, I performed a domain analysis and 
demonstrated that neither the clathrin light chain binding domain nor the clathrin heavy chain 
binding motif were needed for virus infection, whereas the inositol phospholipid binding and F-
actin binding domains were obligatory. In human cell culture, deletion of the human HIPR-1 
orthologs, HIP1 and HIP1R, led to decreased infection by Coxsackie B3 virus, demonstrating a 
conservation of its pro-viral function through evolution. To further establish functional 
conservation, I determined a chimeric HIPR-1 protein harboring the corresponding human HIP1 
inositol phospholipid binding domain was able to rescue Orsay infection in C. elegans. Overall, 
these results provide novel insights into the mechanism of HIP proteins in virus infection, which 
appears to be clathrin binding independent. 
Taken together, I have contributed to the base knowledge of the early C. elegans virology 
field by expanding our narrow knowledge of cellular factors impacting viral infection in C. 
elegans. This increase will better enable the community to explore the nature of the virus lifecyle 





















Viruses are microscopic infectious particles whose core components mainly consist of 
nucleic acid and a protective protein shell (1). Despite being to date the smallest of all replicating 
organisms that we know of, they pose one of the world’s biggest threats to human health (2, 3). 
Massive effects to healthcare and economic systems have even been observed in viral outbreaks 
seen with the 1918 H1N1 Influenza virus and the current 2019 Severe Acute Respiratory 
Syndrome Coronavirus 2 pandemics (2, 3). Therefore, the study and understanding of these 
infectious agents remains paramount for the development of antiviral prevention and treatment 
strategies.  
Although great insights have been achieved in many aspects of the virus life cycle in a 
broad range of hosts, the mechanisms of infection and pathogenesis of these complex virus 
interactions with their host remain poorly understood. However, new models have recently 
emerged as excellent virus systems that can generate unique and valuable insights that may 
complement our current understanding of host-virus interactions (4, 5). The discovery of Orsay 
virus, the first naturally infecting virus of the nematode Caenorhabditis elegans, has recently 
established this multicellular model organism as an excellent system to probe novel host-virus 
interactions, and dissect host mechanisms that mediate virus infection (6-9).  
C. elegans has a long history as an excellent model to study host-microbe interactions 
due to its various proprieties including transparency, short reproduction time, and robust genetic 
tractability (10). While C. elegans has been used extensively as a model for the study of bacterial 
and fungal infections, studies of host-virus interactions and biology were highly limited due to 
the absence of natural viruses of C. elegans (11, 12). Before the naturally infecting Orsay virus 
was discovered, previous studies used a variety of artificial approaches to show various types of 
viruses could infect and replicate within C. elegans cells (13-16). However, these artificial 
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infection experiments could not address key unanswered questions about critical steps of viral 
infection in C. elegans, for example during virus cell surface attachment, penetration, uncoating, 
and egress. Thus, Orsay virus enables an unprecedented opportunity to produce novel insights 
into host mechanisms that mediate viral infection. 
Orsay virus, along with Santeuil and Le Blanc virus which infect Caenorhabditis 
briggsae, represent the first natural viral pathogens in Caenorhabditis nematodes (6, 17). All 
three viruses are positive sense single stranded RNA viruses and have a common intestinal 
tropism, which is non-lethal. These viruses were recently discovered from wild C. elegans and C. 
briggsae isolates, which showed a sick, distorted intestinal phenotype (6, 17). Intriguingly Orsay 
virus has not been reported to be able to infect other Caenorhabditis species, including C. 
briggsae, and similarly Santeuil and Le Blanc virus has not been reported to be able to infect C. 
elegans or other species (6, 17). What regulates these species specific infections remains a key 
outstanding question. 
Orsay virus is distantly related to the Nodaviridae family (6). Orsay virus has a similar 
genome organization to viruses in the family Nodaviridae, with their RNA dependent RNA 
polymerase and capsid proteins having up to 30% in amino acid similarity (6) (Fig. 1). However, 
Orsay virus has two prominent differences compared to Nodaviridae viruses. The first is the 
RNA 2 segment expresses a delta protein as a capsid-delta fusion protein, generated through 
ribosomal frameshifting, which is not present in any known viruses in the Nodaviridae family (6, 
18-20). The function of this delta protein remains a key and interesting question. This capsid-
delta fusion protein co-purified with the major capsid protein (alpha) and viral RNA after density 
gradient centrifugation of Orsay virus, suggesting delta is incorporated into Orsay virons (20). 
The crystal structure of an Orsay virus-like particle assembled from recombinant capsid protein 
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revealed that the C-terminus end of the capsid protein (the side fused to delta proteins) forms 
trimeric protrusions, suggesting the capsid-delta fusion may play a structural role and is located 
outside the capsid (21). A more recent study showed recombinant Orsay capsid containing 
capsid-delta fusion proteins formed long fibers with globular heads at the distal end, and also that 
addition of purified delta proteins to worm culture in a protein- competition assay significantly 
reduced Orsay virus infectivity, suggesting delta may be a key factor in mediating viral entry 
(22). Another study also recently reported the Orsay delta protein was required for nonlytic viral 
egress, as they found the lack of free delta protein production by the virus showed a viral exit 
defect without any obvious defects in replication or other lifecycle steps (23).   
The second notable distinction between Orsay virus and viruses in the Nodaviridae 
family is the lack of a B2 gene (6). Currently there is no evidence suggesting Orsay virus 
encodes a B2 protein, which is a known suppressor of antiviral RNAi, and is translated from a 
subgenomic transcript (called RNA3) located in the RNA1 segment of viruses in the 
Nodaviridae family (24-26). The evolutionary origin of the B2 protein and why Orsay virus 





Figure 1.1. Genome structure of Orsay virus. Orsay virus encodes three proteins, a RNA 






In order to proliferate, viruses must gain entry in host cells, replicate, produce mature 
viruses, and exit to infect new cells, all while exploiting host factors and metabolites (27). 
Although much progress has been made in understanding the mechanisms of positive sense 
single stranded RNA virus replication and propagation in a broad range of hosts, the following 
represent some of the aspects of the Orsay virus lifecycle that have been poorly characterized.  
The mechanism of virion entry is one of these key aspects of the Orsay virus life cycle 
that remains an unanswered question. Enveloped viruses rely on membrane fusion to enter cells 
through the cellular membrane (28). However, non-enveloped viruses, such as Orsay virus, must 
rely on alternative strategies to penetrate cellular membranes, most of which are poorly defined 
and remain key questions (28). Although several membrane receptors and other factors that play 
a fundamental role in the entry of a viruses, have been studied, many more probably have not 
been identified and characterized, including Orsay virus’s receptor. One interesting model 
proposed for entry of noneveloped viruses includes conformational changes of the virion, which 
lead to capsid disassembly and release of small peptides that interact with membranes to mediate 
cell entry (28); however this remains to be investigated in the C. elegans system.   
 The means by which the Orsay virus genome is released into the cytosol is another key 
outstanding question. Various models have been proposed on how this occurs via endocytosis in 
single stranded RNA viruses (29). For example one model proposes that the low pH inside 
endosomes induces capsid structural changes that allow the viral RNA to be secreted through a 
permeablized membrane and into the cytosol (29)l. However the exact mechanisms of virus 
uncoating, and the identity and role of host factors in mediating this process are not well 
understood, especially in the C. elegans-Orsay virus model.  
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 The replication of positive sense single stranded RNA viruses have been extensively 
studied in other viruses, such as Polio virus, however, the processes of Orsay virus replication in 
C. elegans remains a gap in our knowledge (27). Positive sense single stranded RNA viruses 
generally rely upon viral replication proteins that are recruited to intracellular membranes, where 
viral replication complexes are formed. These viral replication complexes mass produce viral 
RNA which either become translated or incorporated into new mature viruses (27). To facilitate 
the RNA replication processes, viral RNA and proteins interact with numerous host factors 
through protein-protein, RNA-protein, and protein-lipid interactions. These interactions along 
with other facilitating host factors, such as membrane remodeling proteins, have yet to be 
identified in C. elegans.  
 Historically, it is thought that non-enveloped viruses, like Orsay virus, depend upon lysis 
of the host cell to spread. The C. elegans intestine is made up of twenty non-renewable intestinal 
cells that form a monolayer tube. As Orsay virus infection is non-lethal, and lysis of one or more 
intestinal cells would be lethal, this suggests Orsay virus uses a non-lytic egress mechanism (6). 
Moreover emerging evidence suggests that non-lytic egress mechanisms for nonenveloped 
viruses exist. The nonenveloped viruses, polio and coxsackievirus B3, have both been observed 
in extracellular membrane vesicles that carry markers of autophagosomes (30, 31). Furthermore 
one study found transmission of polio was dependent on the presence of autophagy proteins (31). 
Other non-enveloped viruses, such as hepatitis A and blue tongue viral particles, have also 
recently been described in membranous vesicles, suggesting that non-canonical egress 
mechanisms may be more common than previously recognized (32, 33). Nevertheless, the 
mechanism by which Orsay virus exits infected cells remains unclear and warrants investigation. 
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 To begin to address these questions and investigate these mechanisms, we previously 
designed a chemical mutagenesis screen to identify in unbiased fashion host factors that are 
essential to support Orsay virus infection (7). This genetic screen utilized the jyls8;rde-1(ne219) 
reporter strain, which expresses green fluorescent protein (GFP) under control of the virus-
inducible gene promoter pals-5. The rde-1 mutant genetic background has a defect in antiviral 
RNAi and renders these animals hypersensitive to Orsay virus, thus virus infection of this strain 
typically leads to GFP expression in greater than 99% of animals. Through this forward genetic 
screen, we previously identified the genes sid-3, which encodes a nonreceptor tyrosine kinase 
and viro-2, which encodes the ortholog of human Wiskott-Aldrich syndrome proteins that has 
been implicated in several pathways including actin polymerization, as host factors essential at 
an early, prereplication step of the Orsay virus life cycle.  An additional essential factor for 
Orsay virus infection nck-1, which its mammalian ortholog is important for actin cytoskeletal 
remodeling, was identified through an RNAi-based reverse genetic screen targeting host factors 
interacting with the mammalian orthologs of sid-3 and viro-2 (7). Furthermore, the human 
orthologs of sid-3, viro-2 and nck-1 (TNK2, WASP and NCK1, respectively) form a pathway 
that is important for infection by multiple viruses in the family Picornaviridae (34). Collectively, 
these previous studies identified the first pro-viral genes in C. elegans and establish that these 
host factors may have evolutionarily conserved functions in mammals.  
 In this dissertation, I further exploit the powerful genetic tools available in C. elegans to 
broaden the narrow list of host factors that enable Orsay virus infection. Through an expansion 
of the previously mentioned forward genetic screen, I identify and characterize two novel host 
factors, dietary restriction-like 1 (drl-1) and huntingtin-interacting protein related 1 (hipr-1) that 
support Orsay virus infection at an early stage of the virus lifecycle. drl-1 is predicted to encode 
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a putative serine-threonine kinase that shares similarities with human mitogen activated protein 
kinases (MAPK), and hipr-1 encodes a predicted adaptor protein that links inositol phospholipids 
to F-actin and clathrin. As hipr-1 had clear mammalian orthologs, in contrast to drl-1 which has 
no clear mammalian ortholog, the human orthologs of hipr-1, HIP1 and HIP1R, were knocked 
out in cell culture and these showed a restrictive effect on Coxsackie B3 virus, demonstrating an 
evolutionarily conservation of its pro-viral role. Domain dissection of the C. elegans HIPR-1 
protein revealed the requirement its inositol phospholipid and F-actin binding domains for its 
pro-viral function, which seemed clathrin light and heavy chain binding independent.   
 Collectively, this work has advanced our knowledge and insights of virus infection in the 
pioneer field of C. elegans virology and enabled the opportunity to further inquiry the 
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 Orsay virus is the only known natural virus pathogen of Caenorhabditis elegans, and its 
discovery has enabled virus-host interactions studies in this model organism.  Host genes 
required for viral infection remain understudied. We previously established a forward genetic 
screen based on a virus-inducible GFP transcriptional reporter to identify novel host factors 
essential for virus infection. Here we report the essential role in Orsay virus infection of the 
Dietary Restriction Like (drl-1) gene, which encodes a serine/threonine kinase similar to the 
mammalian MEKK3 kinase. Ablation of drl-1 led to a >10,000-fold reduction in Orsay virus 
RNA levels, which could be rescued by ectopic expression of DRL-1. DRL-1 was dispensable 
for Orsay replication from an endogenous transgene replicon, suggesting that DRL-1 affects a 
pre-replication stage of the Orsay life cycle. Thus, this study demonstrates the power of C. 
elegans as a model to identify novel virus-host interactions essential for virus infection. 
 
Importance 
The recent discovery of Orsay virus, the only known natural virus of Caenorhabditis 
elegans, provides a unique and novel opportunity to study virus-host interactions that mediate 
infection in a genetically tractable multicellular model organism. As viruses remain a global 
threat to human health, better insights into cellular components that enable virus infection and 
replication can ultimately lead to the development of new targets for antiviral therapeutics.     
 
Introduction  
Orsay virus is the only known natural virus pathogen of Caenorhabditis elegans  . The 
recent discovery of Orsay virus has enabled identification of novel host factors essential for 
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infection and immunity in this classic model organism (8, 12, 35-38). As many C. elegans genes 
and fundamental biological processes are evolutionary conserved in higher Eukaryotes, further 
dissection of virus-host interactions using this novel platform has the potential to identify novel 
insights into basic cellular biology, and targets for antiviral therapeutics. 
Orsay virus is a non-enveloped positive sense single stranded RNA virus most closely 
related to members of the Nodaviridae family (6). Orsay virus has a bipartite genome encoding 
an RNA-dependent RNA polymerase (RdRp) in the RNA1 segment, which is ~3.4 kb. The viral 
capsid protein and a novel capsid-delta fusion protein of unknown function are encoded in the 
RNA2 segment, which is ~2.5 kb (6).     
We previously described an unbiased forward genetic screen to define host factors that 
mediate Orsay virus infection in C. elegans (8). Central to the screen is the jyls8;rde-1(ne219) 
reporter strain, which is hypersensitive to Orsay virus and carries an integrated transcriptional 
GFP reporter under the virus-inducible pals-5 promoter (12). In our previous study, following 
ethyl methanesulfonate (EMS) mutagenesis, two mutants, sid-3(vir9) and viro-2(vir10), were 
isolated that fail to express GFP when challenged with Orsay virus and show a significant defect 
in viral RNA accumulation. sid-3 encodes a non-receptor tyrosine kinase, and viro-2 is an 
ortholog of human Wiskott Aldrich syndrome proteins (N-WASP). These represent the first host 
genes identified to be necessary for Orsay virus infection in C. elegans. Both of these genes are 
required for early, pre-replication steps of the virus life cycle. As the EMS screen in the previous 
study was not saturating, here we expanded the genetic screen to identify another novel host 
gene, drl-1, that is also critical for Orsay virus infection of C. elegans. As with sid-3 and viro-2, 





A forward genetic screen identified a novel host factor critical for Orsay virus infection in 
C. elegans. 
A chemical mutagenesis screen was performed using the previously described jyls8;rde-
1(ne219) strain to identify additional host factors critical for Orsay virus infection in C. elegans 
(8). The goal of the screen was to isolate mutants that failed to express GFP upon virus infection, 
referred to as Viro (virus induced reporter off) mutants.   
Approximately 2,000 haploid genomes were mutagenized with EMS. Initially 127 Viro 
hits were isolated, and after several rounds of validation (i.e. bleaching and reinfection), two 
independent Viro mutants remained. Mating with the previously identified sid-3(vir9) and viro-
2(vir10) mutants demonstrated that one of these Viro mutants belonged to the same genetic 
complementation group as sid-3(vir9), while the other mutant, Viro-4, represented an 
independent complementation group. Viro-4 reproducibly failed to express GFP following Orsay 
virus infection (Fig. 1A). As the microsporidial pathogen Nematocida parisii can also activate 
GFP expression in jyls8;rde-1(ne219), we challenged Viro-4 with N. parisii. The mutant 
displayed intestinal GFP expression, demonstrating the integrity of the GFP transgene, and that 
the failure to induce GFP was virus-specific (Fig. 1A).  
Orsay virus RNA levels in Viro-4 were measured by real-time quantitative reverse 
transcription-PCR (qRT-PCR) 3 days after infection. Compared to the unmutagenized reporter 
strain, Viro-4 showed a >10,000-fold reduction in Orsay viral RNA at 3 days postinfection, 
demonstrating a significant defect in virus RNA production (Fig. 1B). The Orsay virus RNA 
level phenotype in Viro-4 was comparable to those seen in the previously identified sid-3(vir9) 






















FIG 2.1 A chemical mutagenesis screen identified a mutant strain with a defect in GFP 
expression and viral RNA replication. (A) GFP reporter expression of Viro-4 mutants infected 
with Orsay virus or N. parisii at 3 days postinfection. (B) Orsay virus RNA2 levels quantified by 
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real-time qRT-PCR at 3 days postinfection. Values are means plus standard deviations for three 
replicate wells. ****, P < 0.0005. 
 
 
Orsay virus RNA levels in Viro-4 were measured by real-time quantitative reverse 
transcription-PCR (qRT-PCR) 3 days after infection. Compared to the unmutagenized reporter 
strain, Viro-4 showed a >10,000-fold reduction in Orsay viral RNA at 3 days postinfection, 
demonstrating a significant defect in virus RNA production (Fig. 1B). The Orsay virus RNA 
level phenotype in Viro-4 was comparable to those seen in the previously identified sid-3(vir9) 
and viro-2(vir10) mutants (Fig. 1B).  
 
Mutation in the drl-1 gene is responsible for the Viro-4 phenotype. 
To identify the mutation responsible for the virus-resistant phenotype in the Viro-4 
mutant, F2 bulk segregant analysis was performed by outcrossing the strain with the rde-
1(ne219) mutant strain, which is also highly susceptible to Orsay virus infection, as previously 
described (8). Thirty-eight independent F2 cross-progenies that had the GFP and virus-resistant 
phenotype (data not shown) were isolated. Their F3 progenies were pooled and subjected to 
whole genome sequencing, and analyzed using the CloudMap bioinformatic pipeline (39).  
Three candidate mutations were identified in the linked region on chromosome IV: a G-
to-A nonsense mutation which leads to a loss of the splice acceptor site of the ninth exon of the 
drl-1 gene, a G-to-A missense mutation which results in an Asp522Asn amino acid substitution 
in the same drl-1 gene, and a G-to-A missense mutation in the cogc-8 gene which results in an 
Arg360Gln amino acid substitution. drl-1 encodes a putative serine/threonine kinase; RNAi 
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knockdown of drl-1 is reported to lead to an increase in life-span, decrease in fat storage, and 
lower levels of oxidizing agents (40). By BLASTp analysis, the kinase DRL-1 has 26% sequence 
identity (44% sequence similarity) to the human Map kinase kinase kinase (MEKK3), which has 
been shown to function in signaling cascades regulating cellular proliferation, differentiation, 
and inflammatory responses (41-45). cogc-8 encodes a subunit of lobe B of the conserved 
oligomeric Golgi complex, and has been reported as a mediator of gonad morphogenesis and 
gonadal cell migration (46).        
To determine which of these genes was responsible for the GFP and virus-resistant 
phenotype in the Viro-4 mutant, we first performed RNAi knockdown of drl-1 and cogc-8 in the 
drh-1 mutant background, which is hypersensitive to Orsay virus infection and has a functional 
feeding RNAi pathway. RNAi knockdown of drl-1 showed an approximate 10-fold reduction in 
Orsay virus RNA at 2 days postinfection compared to the empty vector, cogc-8 or an irrelevant 
host gene, dpy-3 (Fig 2). These results suggested that drl-1 and not cogc-8 was the causal gene. 
To provide independent validation, we ectopically expressed wild type DRL-1 from a plasmid 
driven by the ubiquitous sur-5 gene promoter in the Viro-4 mutant. Orsay virus infection of this 
complemented strain lead to wild type levels of both GFP expression and Orsay virus RNA at 3 
days postinfection (Fig. 3A and 3B). Likewise, a transgenic strain harboring a fosmid 
encompassing the drl-1 locus also rescued GFP expression and Orsay RNA replication levels 
(Fig. S1A and S1B). These results demonstrated mutation of the gene drl-1 is responsible for the 














FIG 2 RNAi knockdown of candidate casual genes in the drh-1 mutant strain. Real-time 
qRT-PCR of Orsay virus RNA2 levels 2 days after Orsay virus infection of animals fed RNAi 
against independent genes. Values are means plus standard deviations (error bars) for three 
independent biological experiments each with three replicate wells. Statistical significant 
differences were determined by one-way analysis of variance [(ANOVA) (F(3,32) = 14.47, p= < 
0.0001] with a statistical difference identified between empty vector and drl-1 (Dunnett’s 





























FIG 3 Orsay RNA replication and GFP expression patterns in Viro-4 mutants 
overexpressing DRL-1. (A) GFP response at 3 days postinfection of Viro-4 mutants ectopically 
expressing DRL-1 infected with Orsay virus. Pmyo2::YFP plasmid was co-injected as a 
transgenic marker. (B) Orsay virus RNA2 levels at 3 days postinfection of Viro-4 mutants 
overexpressing DRL-1 infected with Orsay virus. ***, P < 0.005.             
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DRL-1 is necessary for a pre-replication step of the Orsay virus life cycle  
 To assess the stage of the Orsay life cycle upon which DRL-1 acts, we generated a 
transgenic drl-1(vir11) strain carrying an extrachromosomal array of plasmids encoding the 
Orsay virus RNA1 segment under control of the heat shock promoter as previously described (8). 
As a control to determine the level of Orsay RNA generated by DNA templated transcription, a 
transgenic drl-1(vir11) strain carrying extrachromosomal arrays of a D601A polymerase dead  
mutant Orsay virus RNA1 was also generated (4, 8). We previously determined that the wild 
type RNA1, but not the D601A mutant, expressed in jyls8;rde-1(ne219) is sufficient to support 
replication of the Orsay virus RNA1 segment as a replicon system and activate GFP expression. 
Heat shock of drl-1(vir11) mutants expressing the wild type Orsay RNA 1 segment induced 
intestinal GFP expression at 3 days after induction whereas the D601A mutant carrying animals 
did not (Fig 4A).  By qRT-PCR, ~ 100-fold more viral RNA was detected in the wild type RNA1 
carrying line than the mutant expressing the polymerase dead mutant Orsay virus RNA1 
segment. The level of Orsay RNA1 replication was comparable to that observed in the analogous 
wild type jyls8;rde-1(ne219) strain (Fig. 4B). These observations demonstrate that absence of 
DRL-1 does not affect Orsay virus replication from an endogenous transgene. Therefore, DRL-1 


























FIG 4 Impact of drl-1 on Orsay virus RNA replication induced from a transgene. (A) GFP 
expression of strains carrying either wild-type or polymerase dead mutant Orsay virus RNA1 
under a heat-inducible promoter in the jyls8;rde-1 or drl-1(vir11) background 3 days after heat 
shock. The Pmyo2::YFP plasmid was co-injected as a transgenic marker. (B) Quantification of 





 The recently established Orsay virus-C. elegans model provides a robust system to define 
host-virus interactions. Initial studies in this nascent field have begun to identify novel pro-viral 
and antiviral factors (8, 12, 35-38). We previously described a forward genetic screening strategy 
to identify pro-viral host factors which identified sid-3 and viro-2 (3). As that pilot screen was 
not saturated, as evidenced by the absence of multiple alleles of the same gene, we extended the 
screen to another 2000 haploid genomes. Here we identified drl-1 as a novel host gene essential 
for Orsay virus infection of C. elegans.  
Only one prior publication has characterized drl-1. It is reported to be a negative 
regulator of lifespan and health, likely through nutrient sensing and metabolic shifts (40). In that 
study RNAi knock down of drl-1 led to an extension in longevity, an increase in fatty acid 
degradation, and a decrease in cellular oxygen reactive species. Whether drl-1 mediates virus 
infection through these pathways or functions in a novel pathway remains to be explored.  
The phenotypes we observed in drl-1(vir11) with respect to Orsay virus infection 
phenocopied our previously reported sid-3(vir9) and viro-2(vir10) mutants. Specifically, in 
addition to the failure to activate GFP following Orsay infection, Orsay RNA levels were 
reduced to comparable levels by >10,000-fold. In addition, DRL-1, like SID-3 and VIRO-2, was 
dispensible for Orsay replication from an endogenous transgene, suggesting that all 3 of these 
genes act at a pre-replication step of the Orsay life cycle. Whether they act together to affect the 
same step or distinct steps is currently unknown. While there is no experimental data directly 
linking DRL-1 to SID-3 or VIRO-2, given that DRL-1 has a reported kinase activity (40), it is 




In contrast to sid-3 and viro-2, which have clear mammalian orthologs, there is no clear 
mammalian ortholog of drl-1. By BLASTp analysis, the human gene with greatest similarity is 
the MEKK3 kinase with 26% sequence identity (44% sequence similarity). MEKK3 is a 
serine/threonine kinase and a member of the mitogen-activated protein kinase (MAPK) family. 
MEKK3 has been reported to regulate signaling pathways, such as ERK, JNK, and p38, involved 
in various cellular processes such as proliferation, differentiation, apoptosis, and inflammatory 
responses in response to extracellular signals and stresses (41-45). MEKK3 is a serine/threonine 
kinase and belongs to the mitogen-activated protein kinase (MAPK) family. MEKK3 has been 
reported to regulate several MAPK signaling pathways, including ERK, JNK, and p38, involved 
in various cellular processes such as proliferation, differentiation, apoptosis, and inflammatory 
responses in response to extracellular signals and stresses (10-14).  
Increasing evidence demonstrate the crucial role of MAPK signaling pathways in viral 
infection and propagation in a range of hosts and viruses. For example, Influenza A virus 
infection virus requires activation of the MAPK/ERK pathway for efficient viral replication, as 
inhibition of this pathway reduces IAV titers in human lung carcinoma cells and mouse lung 
tissues (ref1,3). Conversely, constitutive activation of this pathway yielded higher virus titers in 
cell culture, and enhanced mortality in vivo (2,3). Hepatitis C virus and Coxsackievirus B3 
(CVB3) also upregulate activity of the MAPK cascade upon infection, and inhibiting this 
pathway suppresses both HCV and CVB3 viral replication in cell culture. The pro-viral factor 
DRL-1 represents the first piece of evidence that the MAPK pathway may have a conserved role 
in mediating viral infection in C. elegans, as has been demonstrated in other host-virus systems. 
Future investigation will provide better insights into the mechanism of an evolutionarily 
conserved MAPK pathway in mediating virus infection, or reveal a novel mechanism by which 
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DRL-1 is enabling infection, which can ultimately lead to the development of novel antiviral 
targets and strategies in the future.   
The studies presented here demonstrate the robustness of C. elegans genetics and how 
they can be exploited to uncover novel host factors that promote virus replication and broaden 
our insights on the fundamental biological processes important in virus infection.     
 
Materials and Methods        
C. elegans culture and maintenance.  C. elegans strains WM27 rde-1(ne219), RB2519 drh- 
1(ok3495), were obtained from the Caenorhabditis Genetics Center (CGC) and maintained under 
standard lab culture conditions unless otherwise specified (47). In brief, animals were fed 
Escherichia coli OP50 on nematode growth medium (NGM) plates in a 20°C incubator and 
chunked every 3 to 4 days to a new NGM plate seeded with E. coli OP50. 
 
Orsay virus preparation, infection, and RNA extraction. Orsay virus was prepared by large-
scale liquid culture as described previously (20), filtered through a 0.22-µm filter, and stored at -
80°C. For all infection experiments, animals were bleached and then synchronized in M9 buffer 
(48) in 15-ml conical tubes with constant rotation at room temperature for 16 h. Five hundred 
arrested larval stage 1 (L1) larvae were seeded onto each well of a six-well plate with 20 µl E. 
coli OP50 lawn. L1 larvae were allowed to recover for 20 h at 20°C prior to infection. Orsay 
virus filtrate was thawed at room temperature and then diluted 1:10 with M9 buffer. For each 
well, 20 µl of virus filtrate was added into the middle of the bacterial lawn and incubated at 
20°C. Three days after infection, animals were collected into 1.5-ml Eppendorf tubes by washing 
each well with 1 ml of M9 buffer and then pelleted by spinning for 1 min at 3,000 rpm in a 
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benchtop centrifuge. M9 supernatant was removed, and 300 µl TRIzol reagent (Invitrogen) was 
added to the tubes, and then the tubes were frozen in liquid nitrogen. For each experiment, three 
replicate wells were used for each infection condition, unless otherwise indicated. Total RNA 
from infected animals was extracted using Direct-zol RNA miniprep (Zymo Research) 
purification according to the manufacturer’s protocol and eluted into 30 µl of RNase/DNase-free 
water. 
 
C. elegans feeding RNAi knockdown. RNAi feeding was used for gene knockdown as 
described previously (49). E. coli strain HT115 carrying double-strand RNA expression cassettes 
for genes of interest was induced using established conditions and then seeded into six-well 
NGM plates. dpy-3 and cogc-8 RNAi clones were from the Ahringer RNAi library (50). To 
construct the drl-1 feeding RNAi clone, a 1-kb genomic fragment of the gene was amplified by 
single animal PCR using primers LS86 
(TAAGCAGGATCCATTCTGCTACCAATTATCATTTTGCT) and LS87 
(ATTCGTTGCTTATCATGCAATCTTATCAACACCATAACC). The PCR product was 
digested with BamHI, cloned into pL4440, and transformed in E. coli HT115. Twenty arrested 
L1 drh-1 mutant animals were seeded into each well of a six-well plate. After 72 h of RNAi 
feeding, Orsay virus was added to the plates as described above. At 48 h postinfection the 
infected C. elegans animals were collected, and 300 µl of TRIzol (Invitrogen) was added to each 
well for RNA extraction. 
 
Orsay virus quantification by real-time qRT-PCR. RNA extracted from infected animals was 
subjected to one-step real-time quantitative reverse transcription-PCR (qRT-PCR) to quantify 
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Orsay virus replication as previously described (4). Briefly, the extracted viral RNA was diluted 
1:100, and 5 µl was used in a TaqMan fast virus one-step qRT-PCR with primers and probe 
Orsay_RNA2 that target the Orsay RNA2 segment. Absolute Orsay virus RNA2 copy number 
was determined by comparison to a standard curve generated using serial dilutions of Orsay virus 
RNA2 in vitro transcripts. Primers GW314 and GW315 and probe Orsay_RNA1 that target the 
Orsay virus RNA1 segment were used to quantify Orsay virus RNA1 abundance (20). To control 
for variation in the number of animals, Orsay virus RNA levels were normalized to an internal 
control gene rps-20, which encodes a small ribosomal subunit S20 protein required for 
translation in C. elegans (51). The mean and standard deviation for three replicate wells are 
shown for all experiments. Each experiment was performed in two or more biologically 
independent experiments. Statistical testing was done by Student’s t test, unless otherwise stated. 
Statistically significant comparisons are indicated as follows: *****, P < 0.00005; ****, P < 
0.0005; ***, P < 0.005; **, P < 0.01; *, P < 0.05; NS (for not significant with P < 0.05). 
 
Forward genetic screen for mutants unable to induce GFP expression following Orsay 
virus infection. The jyIs8;rde-1 reporter strain was maintained on 10-cm plates seeded with 1.5 
ml of E. coli OP50. Animals were grown to a stage with a high proportion of L4 larvae and were 
then collected by washing the plates with water. Animals were then treated with 50 mM of EMS 
for 4 h at 20°C with constant rotating. Animals were washed with M9 buffer and recovered on 
10-cm plates for 6 h. 10 L4 P0 animals were transferred to 10 new NGM plate and were allowed 
to lay about 10 F1 eggs each before being removed. F1 animals were washed away from plates 
after each animal laid about 20 eggs. Hatched F2 animals were challenged with 800 µl of a 1:10 
dilution of Orsay virus filtrate per plate and screened for Viro mutants. For complementation 
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assays, eight males of either sid-3(vir9) or viro-2(vir10) mutant strain were backcrossed with two 
hermaphrodites of the Viro mutants to define the ability of their progeny to complement the Viro 
phenotype.   
 
Genetic mapping through F2 bulk segregant and CloudMap analysis. Viro-4 mutants were 
crossed with the WM27 rde-1(ne219) strain, and F1 progenies were chosen and transferred to 
six-well plates. After 3 days, the F2 progenies were challenged with Orsay virus. A total of 72 F2 
Viro animals were picked off F1 plates and transferred to six-well plates. F2 plates were 
replicated after 1 day of laying eggs. The original F2 plates were challenged again with Orsay 
virus, and both virus-induced GFP fluorescence and Orsay virus RNA levels were assayed at 3 
days postinfection. Thirty-eight wells that yielded exclusively Viro animals and that yielded low 
RNA levels from replicated F2 plates were pooled, and genomic DNA from pooled samples was 
extracted using a Qiagen genomic DNA preparation kit according to the manufacturer’s protocol. 
DNA libraries were prepared using Nextera library preparation kit (New England Biolabs) and 
then sequenced using Illumina Miseq-standard. The raw sequence data were analyzed using the 
pipeline CloudMap for C. elegans gene mapping (39).  
 
Plasmid construction for gene overexpression. To construct the drl-1 expression plasmid 
(Psur- 5::drl-1), the entire drl-1 gene was amplified from fosmid WRM0633dH12. The PCR 
product was digested by SacII and NotI and was then ligated into the plasmid containing the sur-




Ectopic trans-complementation with plasmids encoding DRL-1. For rescue of Viro-4, a 
fosmid (WRM0633dH12) or an expression plasmid containing the drl-1 gene was injected into 
the mutant strain at a concentration of 50 ng/µl or 5ng/µl, respectively, along with 5 ng/µl of 
Pmyo-2::YFP as a transgenic marker and 100 ng/µl of DNA ladder (NEB) to help establish the 
array (52). For Orsay virus infection experiments, ten stable transgenic array containing F2 
animals were seeded into each well of a six-well plate. After 72 h of egg laying, Orsay virus was 
added to the plates as described above. At 72 h postinfection the infected animals were assayed 
for GFP fluorescence and collected for RNA extraction and qRT-PCR to assay virus replication.   
 
Epifluorescence and confocal microscopy. The microscopic visual scanning analysis for Orsay 
virus infection was carried out using a Leica stereo fluorescence microscope. Images of C. 
elegans mutant infections were acquired using a Zeiss Axio Imager M2 inverted fluorescence 
microscope equipped with a Hamamatsu Flash4.0 CMOS camera for fluorescence. Briefly, 
young adult to adult C. elegans animals were anesthetized with 1 mM levimisol and then put on 
a 2% dry agarose pad with a coverslip (5 by 5 cm) on top. Images were acquired from both 
fluorescence channels and bright-field channels.  
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Table 2.1 Strains used in this study. 
Lab Name Strain Name Relevant Genotype 
WM27 rde-1(ne219) [rde-1(ne219)V] 
WM28 jyls8 jyIs8[Ppals-5::GFP; Pmyo-2::mCherry] 
















rde-1(ne219) V; sid-3(vir9)X} 
WUM46 viro-2(vir10) 
{jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; 
rde-1(ne219) V; viro-2(vir10)III} 
WUM73 drl-1(vir11) 
{jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; 
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FIG S2.1 Orsay RNA replication and GFP expression patterns in transgenic Viro-4 
mutants carrying a fosmid containing the endogenous drl-1 locus. (A) GFP response at 3 
days postinfection of Viro-4 mutants expressing the endogenous drl-1 locus infected with Orsay 
virus. The Pmyo2::YFP plasmid was co-injected as a transgenic marker. (B) Orsay virus RNA2 
levels quantified by real-time qRT-PCR 3 days postinfection of Viro-4 mutants expressing the 
drl-1 locus. ****, P < 0.0005. 
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3. Huntingtin-interacting protein family members have a 
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Huntingtin-interacting protein family members are evolutionarily conserved from yeast to 
humans, and they are known to be key factors in clathrin-mediated endocytosis. Here we identified 
the C. elegans protein huntingtin-interacting protein related 1 (HIPR-1) as a host factor essential 
for Orsay virus infection of C. elegans. Ablation of HIPR-1 resulted in a greater than ten-thousand 
fold reduction in viral RNA, which could be rescued by ectopic expression of HIPR-1. Viral RNA 
replication from an endogenous transgene replicon system was not affected by lack of HIPR-1, 
suggesting that HIPR-1 plays a role during an early, pre-replication virus life cycle stage. Ectopic 
expression of HIPR-1 mutants demonstrated that neither the clathrin light chain binding domain 
nor the clathrin heavy chain binding motif were needed for virus infection, whereas the inositol 
phospholipid binding and F-actin binding domains were essential. In human cell culture, deletion 
of the human HIP orthologs, HIP1 and HIP1R, led to decreased infection by Coxsackie B3 virus. 
Finally, ectopic expression of a chimeric HIPR-1 harboring the human HIP1 ANTH domain 
rescued Orsay infection in C. elegans, demonstrating conservation of its function through 
evolution. Collectively, these findings further our knowledge of cellular factors impacting viral 
infection in C. elegans and humans. 
 
Significance 
Understanding host-virus interaction mechanisms is critical to identify novel drug targets 
for development of anti-viral therapeutics. The C. elegans-Orsay virus infection system offers an 
innovative approach for discovering host factors required for virus infection. The hipr-1 gene was 
determined to be essential in C. elegans for Orsay virus infection at an early stage of the virus 
lifecycle. Studies of its orthologs in human cell culture determined that both HIP1 and HIP1R are 
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important for Coxsackie B3 virus infection, highlighting the evolutionarily conserved role of HIP-
family proteins in virus infection from nematode to humans.  
 
Introduction   
The identification of novel cellular factors that promote viral infection is key to advancing 
our understanding of the viral life cycle, and it has the potential to yield new therapeutic targets. 
The multicellular model organism Caenorhabditis elegans is naturally infected by Orsay virus, a 
positive sense, non-enveloped RNA virus (1). This infection system has recently been utilized to 
identify several novel host factors that are essential for Orsay virus infection (2, 3). Through an 
unbiased forward genetic screen, the genes sid-3, viro-2 and drl-1 were previously identified as 
host factors essential at an early stage of the Orsay virus life cycle (2, 3). This genetic screen 
utilized the jyls8;rde-1(ne219) reporter strain, which expresses green fluorescent protein (GFP) 
under control of the virus-inducible gene promoter pals-5 (2). In the rde-1 mutant genetic 
background, which renders these animals hypersensitive to Orsay virus, virus infection typically 
leads to GFP expression in greater than 99% of animals.  In this screen, following chemical 
mutagenesis, mutants that fail to express GFP fluorescence are selected (2).  C. elegans nck-1 is 
an additional critical factor for Orsay virus infection identified through an RNAi-based reverse 
genetic screen targeting host factors interacting with the mammalian orthologs of sid-3 and viro-2 
(3).  Moreover, the human orthologs of sid-3, viro-2 and nck-1 (TNK2, WASP and NCK1, 
respectively) form a pathway that is important for infection by multiple viruses in the family 
Picornaviridae (9). In total, these studies establish that key pro-viral genes discovered in C. 
elegans may have evolutionarily conserved functions in mammals.  
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C. elegans HIPR-1 belongs to the huntingtin-interacting protein (4) family, members of 
which have been studied in yeast and mammals. HIP-family proteins have a common domain 
architecture which includes an inositol phospholipid binding AP180 N-terminal homology domain 
(5), a clathrin heavy chain binding motif adjacent to a central clathrin light chain binding coiled-
coil (CC) domain, and a talin-HIP1/R/Sla2p actin-tethering C-terminal homology (THATCH) 
domain, which are thought to link the F-actin cytoskeleton and the clathrin-mediated endocytosis 
pathways (6-12). Biochemical and genetic evidence demonstrate that yeast and human HIP-family 
genes bind and colocalize with clathrin endocytic machinery during endocytosis, and that deletion 
of the yeast HIP-family member Sla2p or knock down of the human HIP1R protein results in 
defects in clathrin-mediated endocytosis (6-12). However, HIPR-1’s biological role in C. elegans 
has not been well studied. C. elegans HIPR-1 is predicted by homology to have all the canonical 
domains characteristic of HIP-family members, although no functional studies of these domains 
have been reported. HIPR-1 modulates presynaptic activity and the abundance of the synaptic 
vesicle fusion regulator synaptobrevin (13). In addition, a genome-wide RNAi screen suggests that 
HIPR-1 may be a regulator of the apical membrane peptide transporter PEPT-1 (14).  
C. elegans HIPR-1 shares 33% and 34% amino acid identity with two human paralogs, 
HIP1 and HIP1R, respectively. The human HIP1 and HIP1R share 48% amino acid sequence 
identity to each other (15). C. elegans HIPR-1 is more distantly related to its yeast ortholog Sla2p 
(15). Mice deficient in HIP1R exhibit viable and fertile (16), although one study identified a gastric 
parietal defect associated with transformation and hypertrophy of the glandular epithelium (17). 
HIP1 deficient mice, on the other hand, exhibit testicular degeneration, spinal defects, 
hematopoietic abnormalities, and cataracts (18, 19); in a separate study, an additional defect in 
AMPA receptor internalization in primary neurons was reported while hematopoiesis was normal 
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(20). Mice deficient in both HIP1 and HIP1R exhibited aggravated spinal abnormalities and 
dwarfism, suggesting existence of a compensatory role of HIP1 and HIP1R (21). HIP proteins may 
be more functionally diverse than previously described as studies in human cell culture have also 
suggested human HIP proteins may play a role in other cellular pathways such as androgen 
receptor transcription and apoptosis (22, 23). Only a few studies have investigated the potential 
role of mammalian HIP1 and HIP1R in virus infection (24-26). In the context of siRNA screens, 
HIP1R has been reported as an important host factor for infection by Venezuelan equine 
encephalitis virus (26), while both HIP1 and HIP1R have been reported as important factors for 
Hepatitis C virus, Polio virus, and Coxsackie B3 virus (CVB3) infection (25, 26). However, little 
is known mechanistically about how these proteins promote virus infection.  
Here we characterize a novel function of HIPR-1 as a host factor essential for Orsay virus 
infection. Its pro-viral function was dependent upon both its ANTH and THATCH domains, but 
not its clathrin binding domains. We demonstrated that the ANTH domain function is conserved 
from C. elegans to humans as the human ANTH domain could replace the C. elegans ANTH 
domain. Deletion of the mammalian orthologs, HIP1 and HIP1R, in human cells led to reduced 
infection of CVB3, which further demonstrates the evolutionarily conserved pro-viral role this 
family plays. Collectively, this study provides novel insights into the mechanism of HIP proteins 
in virus infection, which appears to be clathrin binding independent.  
 
Results 
In Vivo mutagenesis screen for mutants resistant to Orsay virus infection    
To discover new host factors that Orsay virus relies upon for infection, an EMS 
(ethylmethanesulfonate) chemical mutagenesis screen was performed on approximately 2,000 
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haploid genomes in the WUM28 jyls8;rde-1(ne219) worm reporter strain as previously described 
(2) (SI Appendix, Extended Materials and Methods). Two Viro (virus-induced reporter off) mutant 
strains, Viro-5 and Viro-6, demonstrated a defect in GFP expression upon Orsay virus challenge 
at 3 day post infection (dpi) (Fig. 1A). However, when these mutants were challenged with 
Nematocida parisii, a natural fungal pathogen of C. elegans that also activates the GFP 
transcriptional reporter, both Viro-5 and Viro-6 displayed wild-type levels of GFP in response to 
fungal infection, demonstrating a virus-specific defect in GFP activation (Fig. 1A). Orsay RNA 
replication was quantified by quantitative real-time RT-PCR at 3 dpi and revealed a reduction of 
greater than 10,000-fold in both Viro-5 and Viro-6 mutants compared to the unmutagenized 
parental strain (Fig. 1B).  
To determine whether Viro-5 and Viro-6 fell into the same genetic complementation group, 
they were crossed with each other. Viro-5 and Viro-6 fell into the same complementation group, 
suggesting they harbor independent mutant alleles of the same gene (SI Appendix, Fig. S1). 
 
Two independent mutant alleles of hipr-1 are responsible for the virus resistance phenotype 
Two independent approaches were used in parallel to map the phenotype-causing 
mutations in Viro-5 and Viro-6. In the first approach, F2 bulk segregant analysis was performed 
on Viro-6 as previously described (2, 27) (SI Appendix, Extended Materials and Methods). In the 
second approach, the original Viro-5 and Viro-6 mutant strains were each subjected to whole 
genome sequencing (SI Appendix, Extended Materials and Methods). Both approaches yielded 
hipr-1 as the candidate causal gene. hipr-1 in Viro-5 harbored a candidate G-to-A nonsense 
mutation that converts an arginine at position 515 to a premature stop, and hipr-1 in Viro-6 
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contained a candidate G-to-A missense mutation that results in a G773E amino acid substitution 


















FIG 3.1 A chemical mutagenesis screen identified mutant strains with a defect in GFP 
expression and Orsay viral RNA replication. (A) GFP reporter expression of Viro mutants 
infected with Orsay virus or N. parisii at 3 dpi. Pmyo2::mCherry is a transgenic marker. White 
scale bar represents 100µm. BF: bright field. (B) Orsay virus RNA2 levels quantified by real-time 
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qRT-PCR at 3 dpi. The means and standard deviations for three replicates representative of at least 
two independent biological experiments are shown. Statistical significant differences were 
determined by the Student’s t test. ***, P < 0.001. 
 
To determine whether hipr-1 was the causal gene for the Viro-5 and Viro-6 phenotypes, 
we tested the impact of RNAi knockdown of hipr-1 on Orsay virus RNA levels. RNAi knockdown 
of hipr-1 was performed in the drh-1 mutant background. The drh-1 mutant strain  is competent 
for exogenous feeding RNAi yet is hypersensitive to Orsay virus infection due to a defect in 
antiviral RNAi; this strain provides a larger dynamic range to measure changes in Orsay virus 
RNA levels than the wild type N2 (2). At 2 dpi, Orsay virus RNA levels were reduced by over 
1,000-fold compared to the empty vector and non-relevant gene control dpy-3, supporting hipr-1 
as the causal gene (Fig. 2B). As an independent validation, we ectopically expressed the genomic 
locus of hipr-1 under the control of the constitutively active sur-5 gene promoter in both Viro-5 
and Viro-6. At 3 dpi, wild-type levels of GFP expression and Orsay RNA replication were 
observed in both transgenic strains, collectively demonstrating that the mutations in hipr-1 were 
responsible for the Viro phenotypes (SI Appendix, Fig. S2 A and B); Thus, Viro-5 and Viro-6 will 
be referred to as hipr-1(vir12) and hipr-1(vir13), respectively hereafter.    
 





















FIG 3.2 hipr-1 mutant alleles and RNAi knockdown. (A) A hipr-1 genomic structure schematic 
showing the position and identity of hipr-1 mutant alleles in Viro-5 and Viro-6. The coding region 
is represented in blue, UTR sequences in gray, and introns as lines.  *, stop codon. (B) qRT-PCR 
of Orsay virus RNA2 levels 2 dpi of Orsay virus infection of drh-1 animals fed with RNAi against 
targeted genes, non-targeted genes or empty vector. The means and standard deviations for three 
replicates representative of at least two independent biological experiments are shown. Statistical 
significant differences were determined by one-way analysis of variance (ANOVA) with a 
statistical difference identified between empty vector and hipr-1 by Dunnett’s multiple-
comparison test. **, P < 0.01; NS, not significant (P >.05).    
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To explore which HIPR-1 domains are important for Orsay virus infection, the following 
HIPR-1 expression constructs harboring deletions were generated (Fig. 3 A and B): the HIPR-1 
ANTH deletion (△ANTH), which is predicted to abolish binding to inositol phospholipids (9, 10); 
the HIPR-1 coiled-coil domain (△CC), which is predicted to abolish binding to clathrin light chain 
(28, 29); the HIPR-1 THATCH deletion (△THATCH) which is predicted to abolish binding to F-
actin (30, 31); a deletion of the clathrin heavy chain binding motif LLNLA (△CHC) which is 
predicted to abolish binding to clathrin heavy chain, as this consists of the type I consensus clathrin 
box L(L/I)(D/E/N)(L/F)(D/E) (32, 33); a double deletion (△CHC△CC) of both the clathrin-heavy 
chain binding motif and the clathrin-light chain binding coiled-coil domain. All mutations were 
generated in the HIPR-1 expression construct described above fused with mCherry as an 
expression marker, and quantification of the mCherry signal showed all strains were expressed at 
comparable levels as the wild-type HIPR-1::mCherry strain or higher (SI Appendix, Fig. S3). 
Ectopic expression of wild-type HIPR-1::mCherry, HIPR-1::mCherry(△CHC), HIPR-
1::mCherry(△CC), or HIPR-1::mCherry(△CHC△CC) in hipr-1(vir12) was sufficient to rescue 
both GFP expression and Orsay virus RNA replication at 3 dpi, suggesting both HIPR-1’s clathrin 
light chain binding domain and clathrin heavy chain binding motif were dispensable for Orsay 
virus infection (Fig. 4 A, B, C). By contrast, ectopic expression of HIPR-1::mCherry(△ANTH) or 
HIPR-1::mCherry(△THATCH) in hipr-1(vir12) mutants failed to rescue GFP expression and 
Orsay virus RNA replication at 3 dpi, implicating inositol phospholipid and F-actin binding as key 

























FIG 3.3 HIPR-1 domain structure and evolutionary conservation of HIP proteins. (A) A 
schematic depicting HIPR-1’s three predicted evolutionarily conserved domains and clathrin 
heavy chain-binding type I consensus clathrin box. ANTH represents AP180 N-terminal homology 
domain, THATCH represents talin-HIP1/R/Sla2p actin-tethering C-terminal homology domain, 
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CLC represents clathrin light chain, and CHC represents clathrin heavy chain binding motif. (B) 
A schematic depicting the deletions or mutations that were introduced into the HIPR-1 expression 
construct, which were all mCherry-tagged at the C-terminus for visualization of expression. 
Numbers represent the amino acids deleted (C) Neighbor joining phylogenetic tree for HIP 
proteins across species. Scale bar represents amino acid substitution. 
 
 
As four tyrosines in the human HIP1 ortholog were previously reported to be 
phosphorylated by the receptor tyrosine kinase epidermal growth factor receptor (EGFR) (23), and 
this phosphorylation was important for cell survival, we investigated whether phosphorylation of 
the analogous tyrosines in C. elegans HIPR-1 affects Orsay virus infection. As three of these 
tyrosines were conserved in HIPR-1, we engineered a triple tyrosine to phenylalanine (Y-F) non-
phosphorylatable mutant form of HIPR-1 (Fig 3B). Ectopic expression of HIPR-1(3xY-F) in hipr-
1(vir12) was sufficient to rescue both GFP expression and Orsay virus RNA replication at 3 dpi 
(Fig. 4 A and B), suggesting that phosphorylation (or lack thereof) of these three tyrosines in HIPR-
1 does not impact Orsay virus infection.       
 
HIPR-1 affects Orsay virus at an early, pre-replication step of infection  
To investigate which stage of the Orsay virus life cycle HIPR-1 affects, an endogenous 
inducible viral RNA transgene replicon system was generated in hipr-1(vir12) as previously 



















FIG 3.4 GFP reporter expression and virus RNA replication in hipr-1 (vir12) 
transgenic animals overexpressing various HIPR-1::mCherry constructs (A) Intestinal GFP 
expression at 3 dpi of transgenic animals infected with Orsay virus. The Pmyo2::YFP plasmid was 
co-injected as a transgenic marker and is observed as GFP in the pharynx of transgenic animals. 
White scale bar represents 100µm. BF: bright field. (B) Orsay virus RNA2 levels at 3 dpi in 
transgenic hipr-1(vir12) animals overexpressing HIPR-1::mCherry constructs containing a variety 
of mutations. (C) Orsay virus RNA2 levels at 3 dpi in transgenic hipr-1(vir12) animals 
overexpressing HIPR-1::mCherry constructs lacking the clathrin heavy chain motif, coiled-coil 
domain, or both. The means and standard deviations for three replicates representative of at least 
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two independent biological experiments are shown. Statistical significant differences were 
determined by one-way analysis of variance (ANOVA) with a statistical difference identified 
between three post-hoc comparisons analyzed by Sidak’s multiple-comparison test. *, P < 0.05; 
**, P< 0.01; ***, P< 0.001; NS, not significant (P >.05).     
 
 
These transgenic strains carry an extrachromosomal array of plasmids expressing, under control 
of the heat-inducible promoter from hsp-16 genes, either the wild-type Orsay virus RNA1 segment 
or a mutant RNA1 segment harboring an inactivating mutation (D601A) in the RNA-dependent 
RNA polymerase.  The latter strain acts as a control to define levels of DNA-templated 
transcription of the viral transgene. Heat induction of hipr-1(vir12) transgenic strains carrying the 
wild-type viral RNA transgene displayed intestinal GFP expression and Orsay virus RNA1 
replication comparable to levels observed in the wild type strain jyls8;rde-1(ne219) harboring the 
same construct, while transgenic strains expressing the polymerase-dead mutant did not induce 
GFP expression or RNA1 replication (Fig. 5 A and B). Together, these results demonstrated that 
Orsay virus replication initiated from an endogenous transgene is not dependent on HIPR-1, and 





























FIG 3.5 Impact of hipr-1 on Orsay virus RNA replication induced from the RNA1 
transgene. (A) GFP expression of strains carrying wild-type or polymerase dead mutant 
Orsay virus RNA1 under a heat-inducible promoter 3d after heat shock. A Pmyo2::YFP 
49 
 
plasmid was co-injected as a transgenic marker and is observed as GFP in the pharynx 
of transgenic animals. White scale bar represents 100µm. BF: bright field. PHIP: Heat 
inducible promoter. (B) Quantification of Orsay virus RNA1 replication 3d after heat shock 
by real time qRT-PCR. The means and standard deviations for three replicates 
representative of at least two independent biological experiments are shown. Statistical 
significant differences were determined by the Student’s t test. *, P < 0.05; **, P < 0.01. 
 
HIP1 and HIP1R, the mammalian orthologs of C. elegans HIPR-1, are important for CVB3 
infection 
Because HIP-family proteins are evolutionarily conserved from yeast to human (Fig. 3C), 
we evaluated the roles of HIP1 and HIP1R in mammalian virus infection. Both HIP1 and HIP1R 
knock out cells were generated by CRIPSR-Cas9 genome editing in A549 cells, a lung epithelial 
carcinoma cell line (Fig. 6 A and D). Single step infection by CVB3 at MOI 1 showed ~40% 
reduction of infection in HIP1 knock out cells and ~50% reduction of infection in HIP1R knock 
out cells compared to control cells as quantified by flow cytometry analysis of CVB3 positive cells 
(Fig. 6 B and E). In a multi-step growth curve analysis, a 10-fold reduction was seen at late time 
points of virus infection in HIP1 knock out and HIP1R knock out cells (Fig. 6 C and F). Although 
both HIP1 and HIP1R are thought to be important in endocytosis, using fluorescently labeled 
transferrin, a canonical cargo for clathrin mediated endocytosis, analysis by flow cytometry 
demonstrated no defect in transferrin uptake in any of the knock out cells (SI Appendix, Fig. S4), 
which is consistent with previously reported transferrin endocytosis in HIP1 and HIP1R knock out 




Ectopic lentivirus-mediated overexpression of HIP1 or HIP1R in the corresponding knock 
out cells rescued CVB3 infection to control cell levels (Fig. 6 J-M). To evaluate whether HIP1 and 
HIP1R had synergistic roles in virus infection, a HIP1 and HIP1R double knock out A549 cell line 
was generated using the same targeting single guide RNAs (Fig. 6G). Infection of the double 
mutant by CVB3 resulted in similar levels of reduction as either single mutant (Fig. 6H). Similarly, 
a multi-step growth analysis showed that HIP1 and HIP1R double knock out cells had similar 10-
fold reduction of virus production as compared to the control cells (Fig. 6I).  The lack of an additive 
effect of the HIP1/HIP1R knock out suggests that the two genes might function in the same 
pathway.  
HIP1 is known to bind to the N-terminal sequence of huntingtin (34, 35). Thus, we tested 
whether overexpressing the huntingtin N-terminal sequence would influence CVB3 infection. 
Lentivirus mediated expression of the 541 amino acid N-terminus of huntingtin in naïve A549 
cells decreased infection by CVB3 virus as compared to control cells transduced to express firefly 
luciferase (SI Appendix, Fig. S5).  
To determine if CVB3 dependence on HIP1 and HIP1R was specific to the A549 cell line, 
we evaluated both HIP1, HIP1R, and HIP/HIP1R knock outs in the Hap1 cell line, a hematopoietic 
haploid cell line. Infection by CVB3 showed a similar reduction phenotype in HIP1, HIP1R, and 
HIP1/HIP1R double knockouts (SI Appendix, Fig. S6 A-C), demonstrating that their role in 




























FIG 3.6 HIP1 and HIP1R are important for CVB3 virus infection. (A, D, G, J, L) HIP1 and 
HIP1R expression in the knock out and rescued cells detected by Western blot. (B, E, H, K, M) 
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FACS quantification of CVB3 infection on HIP1 and HIP1R knock out and rescued cells 8 hours 
post inoculation. Fluc: firefly luciferase. (C, F, I) Multi-step growth analysis of CVB3 on HIP1, 
HIP1R knock out and double knock out (DKO) cells. The means and standard deviations for three 
replicates representative of at least two independent biological experiments are shown. Statistical 
significant differences were determined by the Student’s t test. *, P<0.05; **, P<0.01; ***, P < 
0.001.      
 
 
The human HIP1 ANTH domain is functional in C. elegans  
              To determine if the human HIP1 ANTH domain is functional in C. elegans, we ectopically 
expressed codon optimized human HIP1 ANTH domain chimeric protein in the C. elegans HIPR-
1 expression backbone by swapping in the human HIP1 ANTH domain (Fig. 7A). Ectopic 
expression in hipr-1(vir12) of the construct carrying the human ANTH domain rescued both virus 
induced GFP expression and the Orsay virus RNA replication phenotypes (Fig. 7 B and C). These 
data demonstrate that the human ANTH domain of HIP1 is functional in C. elegans.   
 
Discussion 
There are only limited studies to date investigating the role of HIP-family proteins in virus 
infection. No studies have previously examined C. elegans HIPR-1 or its yeast ortholog, Sla2p, in 
the context of viral infection. The human ortholog HIP1R is a hit in a siRNA screen for Venezuelan 
Equine Encephalitis Virus infection, and both HIP1 and HIP1R are hits in Hepatitis C Virus, 
Poliovirus, and CVB3 infection screens. Although it has been suggested that these HIP proteins 
likely function in clathrin-mediated endocytosis to promote virus infection, the mechanism has not 
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been investigated fully (24-26). In this study, we exploited the power of C. elegans forward genetic 
screens to define the essential role of HIPR-1 in Orsay virus infection. Moreover, we determined 
that HIPR-1’s function is dependent on its inositol phospholipid and F-actin binding domains but 
















FIG 3.7 Domain swapping between C. elegans HIPR-1 and human HIP1. (A) Domain structure 
for chimeric C. elegans HIPR-1 with human HIP1 ANTH domain. The grey numbers represent 
the amino acids introduced from the human HIP1 ANTH for chimeric construction and the black 
numbers represent the C. elegans amino acid positions. (B) GFP reporter expression of Orsay virus 
54 
 
infection in hipr-1(vir12) strain ectopically expressing C. elegans HIPR-1 with the human ANTH 
domain. A Pmyo2::YFP plasmid was co-injected as a transgenic marker and is observed as GFP 
in the pharynx of transgenic animals. White scale bar represents 100µm. BF: bright field. (C) Orsay 
virus RNA2 quantification in hipr-1(vir12) strain ectopically expressing C. elegans HIPR-1 with 
the human ANTH domain. The means and standard deviations for three replicates representative 
of at least two independent biological experiments are shown. Statistical significant differences 
were determined by the Student’s t test. ***, P < 0.001; NS, not significant (P >.05).      
 
 
In human cells, we determined that both human orthologs of C. elegans HIPR-1, HIP1 and 
HIP1R, were important for CVB3 infection in cell culture, demonstrating the evolutionary 
conservation of HIP-family proteins in supporting virus infection from C. elegans to humans. In 
HIP1 and HIP1R double knock out cells, the absence of an additive effect on virus growth suggests 
that HIP1 and HIP1R act in the same pathway to support virus infection. It is known that HIP1 and 
HIP1R can form both homodimers and heterodimers and this may be important for its endocytic 
function (36-38). Thus, one plausible explanation is that dimerization of HIP1 and HIP1R may 
play a role in promoting virus infection. Consistent with our data demonstrating that HIPR-1 in C. 
elegans acts on an early stage of Orsay virus infection, the ~ 50% reduction in CVB3 infected cells 
in single step infection suggest that HIP1 and HIP1R are likely important for an early step of the 
virus lifecyle. Further studies are required to determine whether these genes might also impact 
later stages of the virus lifecycle. 
The two hipr-1 mutant alleles identified in this study phenocopy the viral replication and 
GFP induction defects observed in the previously identified essential C. elegans host gene mutant 
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alleles sid-3, viro-2, and nck-1 (2).  As the human orthologs of sid-3, viro-2, and nck-1 have since 
been demonstrated to function in a pathway (3), it is intriguing to speculate that hipr-1 may also 
be part of this pathway. However, as all mutant alleles represent null function for Orsay virus 
infection in C. elegans, any genetic endeavor to reveal their relationship remains challenging in C. 
elegans.  
HIPR-1’s cellular function has not been well defined in C. elegans. However, models for 
its yeast and human orthologs propose that HIP proteins are recruited to clathrin pits, where they 
bind the plasma membrane, F-actin, and clathrin to mediate initiation of endocytic vesicles (6, 8, 
10). The domain analysis in this study demonstrated that C. elegans HIPR-1’s inositol 
phospholipids and F-actin binding domains are essential for its function in Orsay virus infection, 
consistent with a model where HIPR-1 couples the plasma membrane and F-actin to mediate 
endocytosis. However, neither HIPR-1’s clathrin heavy chain binding motif nor its clathrin light 
chain binding domain were necessary for Orsay virus infection, suggesting that HIPR-1’s function 
may be clathrin-independent. An alternative possibility is that HIPR-1 indirectly binds to clathrin 
through a separate endocytic factor, as HIP proteins have been reported to bind to other endocytic 
factors, such as to the clathrin adaptor protein 2 (AP2) in human cells and Sla1p in yeast (20, 39). 
While C. elegans HIPR-1 lacks the AP2 DPF binding motif, and there is no Sla1p ortholog in C. 
elegans, there may be additional endocytic binding partners of HIPR-1. It is also plausible that 
HIPR-1 may be mediating clathrin-mediated endocytosis through a clathrin-binding independent 
mechanism.  
The type of inositol phospholipids that C. elegans HIPR-1 binds to remains unknown. 
However, biochemical studies in the yeast ortholog Sla2p have previously reported that it binds to 
PtdIns(4,5)P2 lipids (9), which are primarily found at clathrin-coated pits at the cell surface and 
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are important for recruiting key endocytic machinery (40, 41). Biochemical studies of the human 
orthologs HIP1 and HIP1R, in contrast, show that they preferentially bind to PtdIns(3,4)P2, 
PtdIns(3,5)P2, and to a less extent PtdIns(3)P (43), which are not enriched at the cell surface but 
instead in early and late endosomes, and play an important role in endosomal trafficking and 
protein sorting (42, 43). Together with our results from our chimeric HIPR-1 experiments, which 
demonstrated that the HIP1 ANTH domain was functional in C. elegans, it suggests the 
possibilities that C. elegans HIPR-1 may be acting at or after the internalization step of endocytosis 
during Orsay virus infection.     
In conclusion, our genetic studies have identified HIP-family members as being 
evolutionarily conserved pro-viral host factors from C. elegans to humans. Domain analysis 
elucidated that the HIP protein’s inositol phospholipid-binding and F-actin-binding abilities are 
critical for its pro-viral function in C. elegans, which appears to be clathrin-binding independent. 
Furthermore, this study established the first evidence of functional conservation between HIP-
family member domains across evolution through a C. elegans-human chimeric protein. 
Collectively, these further highlight the power of C. elegans in identifying novel evolutionarily 
conserved host factors critical for virus infection, which can ultimately lead to attractive targets 
for anti-viral therapeutics.   
 
Materials and Methods        
An extended description of the materials and methods used in this study is provided in SI 
Appendix, including the following: chemical mutagenesis screen, genetic mapping of the 
phenotype-causing mutations in Viro-5 and Viro-6, mCherry fluorescence quantification, 




C. elegans culture and maintenance.  We obtained C. elegans strains WM27 rde-1(ne219), 
RB2519 drh-1(ok3495) from the Caenorhabditis Genetics Center (CGC) and maintained them 
under standard lab culture conditions unless otherwise specified (Table 1). In summary, animals 
were fed Escherichia coli OP50 on nematode growth medium plates in a 20°C incubator and 
chunked every 3 to 4 days to a new NGM plate seeded with E. coli OP50. 
 
Orsay virus preparation, infection, and RNA extraction. Orsay virus was prepared by large-
scale liquid culture as described previously (8), filtered through a 0.22-µm filter, and aliquots were 
stored at -80°C. For all Orsay virus infection experiments, animals were bleached and then 
synchronized in M9 buffer in 15-ml conical tubes with constant rotation at room temperature for 
16 h. In six-well plates with 20 µl E. coli OP50, five hundred arrested larval stage 1 (L1) larvae 
were seeded. L1 larvae were allowed to recover for 20 h at 20°C prior to infection. Orsay virus 
filtrate was thawed and brought to room temperature and then a 1:10 dilution was made with M9 
buffer. For each well, 20 µl of virus filtrate was added into the middle of the bacterial lawn and 
the infection was incubated at 20°C. At 3 dpi animals were collected into 1.5-ml Eppendorf tubes 
by rinsing each well with 1 ml of M9 buffer and then spun down by spinning for 1 min at 3,000 
rpm in a benchtop centrifuge. M9 supernatant was removed, and 300 µl TRIzol reagent 
(Invitrogen) was added to the tubes, and they were frozen in liquid nitrogen. For Orsay virus 
infection assays an input control was included consisting of input virus that was incubated in an 
empty well for the duration of the experiment and subsequently mixed with an uninfected well of 
animals immediately prior to RNA extraction, to control for any degradation of the input virus in 
the absence of any replication. For each experiment, three replicate wells (technical replicates) 
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were used for each infection condition, unless otherwise indicated. Total RNA from infected 
animals was extracted using Direct-zol RNA miniprep (Zymo Research) purification according to 
the manufacturer’s protocol and eluted into 30 µl of RNase/DNase-free water. For all N. parisii 
infection experiments, animals were bleached and then synchronized in M9 buffer in 15-ml conical 
tubes with constant rotation at room temperature for 16 h. In six-well plates with 20 µl E. coli 
OP50, five hundred arrested larval stage 1 (L1) larvae were seeded. L1 larvae were allowed to 
recover for 20 h at 20°C prior to infection. N. parisii spores were thawed and brought to room 
temperature and then a 1:10 dilution was made with M9 buffer. For each well, 20 µl of diluted N. 
parisii spores (10,000 spores/animal) was added into the middle of the bacterial lawn and the 
infection was incubated at 20°C. At 3 dpi animals were assayed for GFP fluorescence. For all the 
infection experiments, at least two independent biological experiments (performed on different 
days) were performed. 
 
C. elegans feeding RNAi knockdown. Genes were knocked down by RNAi feeding as described 
previously (8). E. coli strain HT115 carrying double-strand RNA expression cassettes for genes of 
interest was induced using established conditions and then seeded into six-well NGM plates. dpy-
3 and hipr-1 RNAi clones were from the Ahringer RNAi library (50). Twenty arrested L1 drh-1 
mutant animals were seeded into each well of a six-well plate. After 72 h of RNAi feeding, Orsay 
virus was added to the plates as described above. At 2 dpi the animals were collected, and 300 µl 
of TRIzol (Invitrogen) was added to each well for RNA extraction. 
 
Orsay virus quantification by real-time qRT-PCR. RNA extracted from infected animals was 
subjected to one-step real-time quantitative reverse transcription-PCR (qRT-PCR) to quantify 
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Orsay virus replication as previously described (8). The extracted RNA was diluted 1:100, and 5 
µl was used in a TaqMan fast virus one-step qRT-PCR with primers GW303, GW304, and probe 
Orsay_RNA2 (Table S1) that target the Orsay RNA2 segment. Primers GW314, GW315, and 
probe Orsay_RNA1 that target the Orsay virus RNA1 segment were used to quantify Orsay virus 
RNA1 abundance. To control for variation in the number of animals per well, Orsay virus RNA 
levels were normalized to an internal control gene rps-20, which encodes a small ribosomal subunit 
S20 protein required for translation in C. elegans, using primers KC291, KC292, and probe rps-
20_e3-4. Absolute Orsay virus RNA2, RNA1, and C. elegans rps-20 copy number was determined 
by interpolation of a standard curve generated using serial dilutions of in vitro transcripts of Orsay 
virus RNA2, RNA1, and C. elegans rps-20 respectively. The mean and standard deviation for three 
replicate wells are shown for all experiments. Statistical testing was done by Student’s t test or 
one-way analysis of variance. Statistically significant comparisons are indicated as follows: ****, 
P < 0.0001; ***, P < 0.001 ; **, P < 0.01; *, P < 0.05; NS (for not significant with P > 0.05).  
 
Forward genetic screen for mutants that fail to activate GFP expression following Orsay 
virus infection. The jyIs8;rde-1 reporter strain was maintained on 10-cm plates seeded with 1.5 
ml of E. coli OP50. Animals were grown to a stage with a high proportion of L4 larvae and were 
then collected by rinsing the plates with water. Animals were then treated with 50 mM of EMS for 
4 h at 20°C with constant rotation, washed with M9 buffer and recovered on 10-cm plates for 6 h. 
10 L4 P0 animals were transferred to 10 new NGM plate and were allowed to lay about 10 F1 eggs 
each before being removed. F1 animals were washed away from plates after laying about 20 eggs 
for each animal. Hatched F2 animals were challenged with 800 µl of the standard virus filtrate 
dilution for infection and screened for Viro mutants. For complementation assays, eight males of 
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one Viro mutant were crossed with two hermaphrodites of another Viro mutant to define the ability 
of their progeny to complement the Viro phenotypes.   
 
Mapping the causal gene mutation through F2 bulk segregant and CloudMap analysis. As 
previously described (8), hipr-1(vir13) mutants were crossed with the WM27 rde-1(ne219) strain, 
and F1 progenies were chosen and transferred to six-well plates. After 2 days, the F2 progenies 
were infected with Orsay virus at the standard 1:10 dilution of the virus filtrate. At 3 dpi of the F1 
plates, 72 F2 Viro animals were picked off F1 plates and transferred to six-well plates. F2 plates 
were replicated after 2 days of laying eggs. The original F2 plates were challenged again with 
Orsay virus, and both GFP expression and viral RNA replication phenotypes were tested at 3 dpi. 
Forty-two wells that yielded Viro animals and that yielded low RNA levels from replicated F2 
plates were pooled, and genomic DNA from pooled samples was extracted using a Qiagen genomic 
DNA preparation kit according to the manufacturer’s protocol. DNA libraries were prepared using 
Nextera library preparation kit (New England Biolabs) and then sequenced using Illumina Miseq-
standard. The raw sequence data were analyzed using the pipeline CloudMap for C. elegans gene 
mapping (39).  
 
Plasmid construction for hipr-1 ectopic expression. To construct the hipr-1 expression plasmid 
(Psur-5p::hipr-1), the entire hipr-1 gene was amplified from N2 genomic DNA using primers 
LS188 and LS195 (Table S1). The PCR product was digested by SacII and NheI and subsequently 
ligated into the plasmid containing the sur-5 promoter previously described (2). To construct the 
hipr-1::mCherry expression plasmid (Psur-5::hipr-1::mCherry), the hipr-1 gene lacking its stop 
codon was amplified from the Psur-5p::hipr-1 using primers LS188 and LS300 (Table S1). The 
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PCR product was digested by SacII and NotI and then ligated into a plasmid containing the sur-5 
promoter and the mCherry gene with a 15bp linker, amino acid sequence SGAAA, at the 5’ end 
of mCherry. Primers for site-directed mutations were generated by Agilent QuikChange Primer 
Design. Site-directed mutagenesis primers LS396 and LS397, LS398 and LS399, and LS400 and 
LS401 (Table S1) were used to introduce the desired amino acid substitutions for the 3xY-F 
construct, Y111F, Y118F, and Y211F respectively. Site-directed mutagenesis primers LS447 and 
LS448 (Table S1) were used to introduce the desired CHC motif deletion of amino acids 307 to 
311 into the Psur-5::hipr-1::mCherry plasmid. The NEBuilder HiFi DNA Assembly Cloning Kit 
was used to generate the following three domain deletions in the Psur-5::hipr-1::mCherry 
construct: a 933bp that deleted parts of exon 1 and 3 and the entire intron 2, and that corresponded 
to a deletion of amino acids 11 to 285 (ANTH domain), a 1368bp deletion that deleted exons 4, 5, 
introns 3, 4, 5, and parts of exon 3 and 6 and corresponded to a deletion of amino acids 333 to 527 
(coiled-coil domain), and a 999bp deletion that deleted parts of exon 8 and 9 and the entire intron 
8, and that corresponded to a deletion of amino acids 713 to 917 (THATCH domain). To generate 
the Psur-5::hipr-1::mCherry plasmid with a deletion of both the CHC motif and coiled-coil 
domain, site-directed mutagenesis primers LS447 and LS448 (Table S1) were used to introduce 
the CHC motif deletion of amino acids 307 to 311 into the Psur-5::hipr-1::mCherry plasmid that 
contained a deletion of amino acids 333 to 527 (coiled-coil domain).  
          To construct the human HIP1 ANTH domain expression construct in C. elegans HIPR-1 
expression plasmid, C. elegans HIPR-1 cDNA were reverse transcribed, PCR amplified using 
primers LS188 and LS 195 and then cloned in the Psur-5 expression vector. The corresponding 
human HIP1 ANTH domain (primers HJ 454 and HJ 455) and the C. elegans HIPR-1 backbone 
(primers HJ 456 and HJ 457) were PCR amplified with ~20 nucleotide overlapping region and 
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FLAG tagged at the C-terminus. The resulting PCR fragments were gel purified and assembled 
with the Psur-5 expression vector through the NEBuilder HiFi DNA assembly kit according the 
manufacturer’s protocol. Each plasmid sequence was confirmed by Sanger sequencing.       
 
Generating transgenic animals trans-complemented with plasmids encoding HIPR-1. For 
rescue of hipr-1(vir12) and hipr-1(vir13), an expression plasmid containing the hipr-1 gene was 
injected into the mutant strain at a concentration of 5ng/µl, along with 5 ng/µl of Pmyo-2::YFP as 
a transgenic marker and 100 ng/µl of a 2-Log DNA ladder (New England Biolabs) to help establish 
the array. For rescue experiments in hipr-1(vir12) with HIPR-1::mCherry or HIPR-
1::mCherry(ΔCC) mutant constructs, the expression plasmid containing either construct was 
injected into the mutant strain at a concentration of 5ng/µl, along with 5 ng/µl of Pmyo-2::YFP as 
a transgenic marker and 100 ng/µl of a 2-Log DNA ladder. For rescue experiments in hipr-1(vir12) 
with HIPR-1::mCherry(ΔANTH), HIPR-1::mCherry(ΔCHC), HIPR-1::mCherry(ΔTHATCH), 
HIPR-1::mCherry(3xY-F), or HIPR-1::mCherry(ΔCHC ΔCC)  mutant constructs, the expression 
plasmid was injected into the mutant strain at a concentration of 20ng/µl, along with 5 ng/µl of 
Pmyo-2::YFP as a transgenic marker and 100 ng/µl of a 2-Log DNA ladder. For Orsay virus 
infection experiments, five stable transgenic array containing animals were seeded into six-well 
plates with 20 µl E. coli OP50. After 72 h of egg laying, Orsay virus was added to the plates as 
described above. At 3 dpi animals were assayed for GFP fluorescence and collected for RNA 
extraction and qRT-PCR to assay virus replication. For heat induction experiments, 5 stable 
transgenic array containing animals were seeded into six-well plates with 20 µl E. coli OP50. After 
72 h of egg laying, animals were incubated at 33°C for 2 h and then maintained at 20°C for 3 days. 
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At 72 h after heat shock, animals were assayed for GFP fluorescence and collected for RNA 
extraction and qRT-PCR to assay virus RNA replication.    
 
Phylogenetic tree construction. HIP protein amino acid sequences of different species were 
downloaded from Genbank and aligned by ClustalX (version 2.1). Bootstrap neighbor joining tree 
was generated by ClustalX (version 2.1). The number of bootstrap trials was set at 1000 replicates. 
Radial tree was exported from TreeView (version 1.6.6). 
 
Epifluorescence microscopy. The microscopic visual scanning analysis for Orsay virus infection 
was carried out using a Leica stereo fluorescence microscope. Images of C. elegans infections 
were acquired using a Zeiss Axio Imager M2 inverted fluorescence microscope equipped with a 
Hamamatsu Flash4.0 CMOS camera for fluorescence. Young adult to adult C. elegans animals 
were anesthetized with 1 mM      levamisole and then put on a 2% dry agarose pad with a coverslip 
(5 by 5 cm) on top. Images were acquired from both fluorescence channels and bright-field 
channels.  
 
Cell culture, knock out cell line generation and virus infection. A549 cells were obtained from 
the Michael Diamond lab. Cells were maintained in DMEM with 25 mM HEPES, 2 mM L-
glutamine, 1X non-essential amino acids, 10% Fetal bovine serum (FBS) and 100 units/ml 
antibiotics (penicillin and streptomycin). Hap1 cells were obtained from Horizon and cultured in 
IMDM with 10% FBS and 100u/ml antibiotics. Hela cells were obtained from ATCC and were 
cultured in DMEM with 10% FBS and 100 u/ml antibiotics. A549 cells were transduced by 
lentiviruses that express the corresponding sgRNA (Table S1) and Cas9 protein. Transduced cells 
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were passaged two days later and then selected with 2 μg/ml puromycin for 7 days. Cells were 
passaged once during this selection. Clonal selection was performed through limiting dilution in 
96-well plates. After two weeks, single cell clones were picked and expanded in 24-well plates. 
The desired genome editing was identified by a restriction enzyme digestion-based genome typing 
assay and the ablation of protein expression was confirmed by Western blot with anti-HIP1 
monoclonal  antibodies 4B10 (ThermoFisher Scientific) and anti-HIP1R monoclonal antibodies 
1E1 (ThermoFisher Scientific). For infection quantification by FACS assay, cells were seeded one 
day before infection into 96-well plates. Approximately 16 hours after seeding, cells were infected 
by CVB3 at a MOI of 1. One hour after infection, the inoculum was removed and cells were 
cultured in DMEM with 2% FBS. 8 hours post infection, cells were trypsinized and fixed with 4% 
paraformaldehyde. Fixed cells were then permeabilized with perm buffer (1g Saponin, 10ml 
HEPES, 0.025% Sodium Azide in 1L HBSS) for 15 minutes. After permeabilization, cells were 
incubated with primary antibodies for one hour and then washed twice before incubation with 
fluorescently conjugated secondary antibodies. After one hour of secondary antibody incubation, 
cells were washed three times with perm buffer and then resuspended with 70 μl of FACS buffer 
P2F (PBS with 2% fetal bovine serum). Infected cells were then analyzed and quantified through 
MACS flow cytometry (Miltenyi Biotec).  For multistep growth analysis, cells were infected by 
CVB3 at an MOI of 0.01. One hour after inoculation, cells were washed 5 times with serum free 
DMEM and were then cultured in DMEM with 2% FBS. Culture supernatant was collected at time 
0, 6, 12, 24, 36 and 48 hours post infection. Viruses released in the culture supernatant were titrated 
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Table 3.1 Strains used in this study 
Lab Name Strain Name Relevant Genotype 
WM27 rde-1(ne219) [rde-1(ne219)V] 
















rde-1(ne219) V; drl-1(vir11)IV} 
WUM78 hipr-1(vir12) 
{jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; 
rde-1(ne219) V; hipr-1(vir12)III} 
WUM79 hipr-1(vir13) 
{jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; 
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Extended Material and Methods 
Forward chemical mutagenesis screen to identify mutants that fail to activate GFP 
expression upon Orsay virus infection 
To discover new host factors that Orsay virus relies upon for infection, a forward genetic 
mutagenesis screen was performed in the WUM28 jyls8;rde-1(ne219) worm reporter strain. The 
chemical mutagen, EMS (ethyl methanesulfonate), was used to mutagenize approximately 2,000 
haploid genomes. Out of the 247 initial Viro (virus-induced reporter off) hits, various mutant 
strains consistently reproduced the Viro phenotype after two rounds of bleaching and reinfection.   
To determine whether three isolated Viro mutants, Viro-5, Viro-6, Viro-7, fell into the same 
genetic complementation group, Viro mutants were crossed with each other. Two of the Viro 
mutants, Viro-5 and Viro-6 fell into the same complementation group, suggesting they harbor 
independent mutant alleles of the same gene, while Viro-7 formed a distinct complementation 
group (Fig S1). Viro-6 also complemented another previously isolated Viro mutant, drl-1(vir11), 
suggesting it is distinct from drl-1 (Fig S1).  
 
Mapping the causal gene mutation through F2 bulk segregant and CloudMap analysis 
Two independent approaches were used in parallel to map the phenotype-causing mutations in 
Viro-5 and Viro-6. First, F2 bulk segregant analysis was performed on Viro-6 using a previously 
described approach (1). Viro-6 was outcrossed with the rde-1(ne219) mutant strain, and 42 
independent F2 cross-progenies displaying the Viro phenotype were isolated. A pooled 
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collection of their F3 offspring were subjected to whole-genome sequencing, and analyzed using 
the CloudMap bioinformatic pipeline to identify the region of the genome that is linked to the 
phenotype-causing variant. The F2 bulk segregant analysis identified a linked region on 
chromosome III encompassing two candidate point mutations. The first was a G-to-A missense 
mutation in the hipr-1 gene, which results in a G773E amino acid substitution (Fig. 2A). The 
second was a G-to-A missense mutation in the T23G5.3 gene, which generates a P111L amino 
acid substitution. In the second approach, the original Viro-5 and Viro-6 mutant strains were 
each subjected to whole genome re-sequencing in order to identify mutations in common genes 
between both strains. Cross-referencing genes harboring independent mutant alleles between 
Viro-5 and Viro-6 revealed two candidate genes, hipr-1 and Y95B8A.8. hipr-1 in Viro-5 harbored 
a G-to-A nonsense mutation that converts an arginine at position 515 to a premature stop, and 
hipr-1 in Viro-6 contained the previously mentioned mutation (Fig. 2A). Y95B8A.8 in Viro-5 
contains a G-to-A missense mutation that creates an E144K substitution, and in Viro-6 carries a 
G-to-A point mutation that leads to a loss of the splice donor site downstream of the sixth exon. 
Thus, both approaches yielded hipr-1 as the candidate gene. 
 
mCherry fluorescence quantification of HIPR-1::mCherry overexpressing strains 
 
           Twenty-five random young adult transgenic animals were anesthetized with 1mM 
levamisole and then loaded onto a 2% dry agarose pad with a coverslip (5 by 5 cm) on top. 
Images in both bright-field and fluorescence channels were acquired using a Zeiss Axio Imager 
M2 inverted fluorescence microscope equipped with a Hamamatsu Flash4.0 CMOS camera for 
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fluorescence. ImageJ software was used to quantify fluorescence intensity. A line was made 
encompassing the body of each individual worm below their pharynx on the bright-field image 
and then superimposed to its respective mCherry image to measure raw mCherry fluorescence 
intensity of each worm. The pharynx was excluded as these transgenic animals carry a Pmyo-
2::mCherry transgenic marker that produces an mCherry signal in the pharynx that is 
independent of the ectopically expressed HIPR-1::mCherry signal. Twenty-five worms per strain 
were quantified per experiment and two independent biological experiments were performed per 
strain. 
 
Transferrin uptake assay  
Cells were seeded in 24-well plate one day prior to the experiment at 1X105 cell per well. 24 
hours after seeding, cells were serum starved for 1 hour by culturing in serum free DMEM 
(Invitrogen). Fluorescently labeled transferrin (Invitrogen) was incubated with starved cells on 
ice at a concentration of 5 g/ml in DMEM for 30 minutes. Cells were then allowed to 
endocytosis for 15 minutes by incubation at 37°C. Following endocytosis, the cells were washed 
once by acid washing buffer (100 mM glycine, 150 mM NaCl, pH 3.0) and then washed twice by 
DMEM. Cells were then trypsinized and fixed by 4% paraformaldehyde. Endocytosed transferrin 
was quantified and analyzed by MACS flow cytometry.  
 
N-terminal Huntingtin expression and CVB3 infection 
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The N-terminal part (amino acids 1-541) of human Huntingtin were PCR amplified from plasmid 
(EX-Z2776-M02, GeneCopoeia) by primers HJ509 and HJ510 (Table S1) and then cloned into 
pFCIV lentivirus packaging plasmid digested by AscI and AgeI. Lentivirus were packaged as 
described in the main text. A549 cells were transduced with lentivirus packaged with Huntingtin 
N-terminus or firefly luciferase at a MOI of 5. Lenti-transduced cells were then passaged for two 
times before CVB3 infection. Infection by CVB3 was performed and quantified by MACS flow 
cytometry as described in the main text.  
Table S3.1 List of PCR primers, sgRNA oligos and probe sequences. 
























































FIG S3.1 Orsay RNA replication of Viro mutants crossed in complementation assays. Orsay 
virus RNA2 levels at 3 dpi of Viro mutants. Each bar represents values from a single well 


















FIG S3.2 Orsay RNA replication and GFP expression patterns in Viro-5 and Viro-6 
mutants overexpressing HIPR-1. (A) GFP response at 3 dpi of Viro-5 and Viro-6 mutants. The 
Pmyo2::YFP plasmid was co-injected as a transgenic marker. (B) Orsay virus RNA2 levels at 3 
77 
 
dpi of Viro-5 mutant. The means and standard deviations for three replicates are shown. 
Statistical significant differences were determined by the Student’s t test. ***, P < 0.001. (C) 
Orsay virus RNA2 levels at 3 dpi of Viro-6 mutant. The means and standard deviations for three 
replicates representative of at least two biological independent experiments are shown. Statistical 














FIG S3.3 Quantification of mCherry fluorescence in transgenic animals overexpressing  
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variants of HIPR-1::mCherry. Quantification of the fluorescence intensities of transgenic 
worms. mCherry fluorescence was quantified using ImageJ software. The means and standard 
deviations for twenty-five worms representative of two biological independent experiments are 
shown. Statistical significant differences were determined by one-way analysis of variance 
(ANOVA) with a statistical difference identified between five post-hoc comparisons analyzed by 
Dunnett’s multiple-comparison test. ***, P< 0.001; ****, P< 0.0001; NS, not significant (P 









FIG S3.4 Transferrin uptake in HIP1 KO, HIP1R KO and HIP1/HIP1R DKO cells. 
Fluorescence intensity was quantified by flow cytometry, AU: arbitrary unit. Statistical 












FIG S3.5 Effect of Huntingtin N-terminus expression on CVB3 infection. A549 cells were 
transduced with Huntingtin N-terminus and firefly luciferase and then infected by CVB3 at MOI 
1 for 8 hours. CVB3 infection rate was quantified by flow cytometry. Fluc: firefly luciferase, 
HTTN: huntingtin N-terminus. Statistical significant differences were determined by the 






















FIG S3.6 HIP1 and HIP1R are important for CVB3 virus infection. (A-C) FACS 
quantification of CVB3 infection on HIP1 and HIP1R knock out and double knock out (DKO) 
HAP1 cells 8 hours post inoculation. The means and standard deviations for three replicates 
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representative of at least two biological independent experiments are shown. Statistical 




































Despite much progress, there are still many gaps remaining in our understanding of 
fundamental virology. The identification and characterization of host factors and resources 
viruses rely on throughout its lifecycle remains a major challenge in the development of antiviral 
therapeutics.    
Here, I recognized the underrepresentation of known pro-viral host factors and addressed 
these limitations using C. elegans virology to identify novel pro-viral host factors in C. elegans, 
and then using these new factors to pursue questions related to the steps of the viral life, 
functional protein domains, and conserved roles across evolution.      
By generating mutants resistant to Orsay virus infection, I was able to identify drl-1 as a 
novel host factor necessary for Orsay virus infection. Although it is clear that DRL-1 acts at an 
early, upstream of viral RNA replication step of the viral life cycle, it is unclear what the 
mechanism of DRL-1 is for supporting Orsay virus infection. A major challenge in better 
understanding the role of DRL-1 is the lack of literature on its function in C. elegans as well as 
the lack of a clear ortholog in other well-studied organisms, the most similar mammalian 
ortholog being the human MAPK pathway kinase MEKK3. In C. elegans, only one previous 
study has characterized drl-1. It is reported to be a negative regulator of lifespan and health, 
possibly through nutrient sensing and metabolic shifts (1). Knockdown of drl-1 through RNAi 
showed an extension in longevity, an increase in fatty acid degradation, and a decrease in cellular 
reactive oxygen species (1). Whether drl-1’s role in virus infection functions through these 
pathways or functions in a novel pathway remains to be investigated. The most similar ortholog 
of DRL-1 that has been previously studied is the S. cerevisiae Rad53 protein, a serine threonine 
kinase important for DNA damage repair in yeast. However, it is unclear whether this function is 
conserved in C. elegans, or how it would affect Orsay virus infection and replication. Despite 
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these challenges, several approaches can be used in the future to investigate the mechanism of 
DRL-1 in enabling Orsay virus infection. One approach would be to determine what other host 
factors and machinery DRL-1 interacts with by defining its protein interactome through 
coimmunoprecipitation pull down experiments, and evaluating whether it interacts with any of 
the other MAPK pathway proteins. Another approach would involve generating the knockout of 
the predicted human ortholog, MEKK3, and evaluating whether this could restrict replication of 
mammalian viruses.       
To further broaden our knowledge of host factors supporting Orsay virus infection in C. 
elegans, I expanded our chemical mutagenesis screens to discover an additional critical host 
factor, hipr-1, required for Orsay virus infection. I identified HIPR-1 acted at an early step of the 
viral life cycle, upstream of replication. However, future experiments are required to further 
define the exact limiting step in hipr-1 mutants. One method that can provide some insights 
involves performing single-molecule RNA fluorescence in situ hybridization to visualize Orsay 
virus RNA transcripts and determine whether they display intracellular localization in hipr-1 
mutants, failure of which would suggest failure of virus internalization.  
I used previous literature of the HIP protein family and predicted structural protein 
domains in HIPR-1 to identify the obligate domains required for HIPR-1’s function in supporting 
Orsay virus infection (2-8). My domain dissection identified inositol phospholipid and F-actin 
binding domains as necessary for HIPR-1’s ability to support Orsay virus infection, while the 
clathrin light chain and heavy chain domains were dispensible. As HIP protein family members 
in yeast and mammals have been previously reported as key endocytic factors for clathrin-
mediated endocytosis, my findings now pose several intriguing models for HIPR-1’s function in 
Orsay virus infection (2-8). The first proposes HIPR-1 supports virus infection through the 
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clathrin-mediated pathway by indirectly binding to clathrin through a separate endocytic factor, 
as HIP proteins have been reported to bind to other endocytic factors, and preliminary data from 
our lab found RNAi knockdown of clathrin heavy chain in C. elegans restricted Orsay virus 
RNA replication (9, 10). However future experiments are needed to support this model. One 
approach involves demonstrating HIPR-1 plays an important for in clathrin-mediated 
endocytosis in C. elegans. Here, a C. elegans transgenic strain expressing a GFP-tagged human 
transferrin clathrin-specific cargo marker could be used to evaluate any clathrin-mediated 
endocytosis defects in the hipr-1 mutant background (11, 12) . Another approach involves 
determining whether Orsay virus and HIPR-1 intracellularly colocalize with clathrin vesicles 
upon virus infection. An alternative model for HIPR-1’s function in Orsay virus infection 
proposes that HIPR-1 mediates Orsay virus infection through clatrhin-mediated endocytosis by a 
clathrin-binding independent mechanism. Previous studies of the yeast ortholog Sla2p have 
reported its inositol phospholipid binding domain is responsible for its localization to clathrin-
coated pits on the cellular membrane, thus it is possible HIPR-1 in C. elegans is recruited sites of 
clathrin-mediated endocytosis through its inositol phospholipid binding domain, which I 
demonstrated to be required for its function in Orsay virus infection (5, 6). It is also plausible 
that HIPR-1’s function in Orsay virus infection is clathrin-independent, as other examples of 
nonenveloped RNA viruses entering the host cell through clathrin-independent pathways have 
been previously reported, such as those observed with polio virus and CBV3 virus (13, 14).    
I next identified both human orthologs of C. elegans HIPR-1, HIP1 and HIP1R, as 
important for CVB3 infection, demonstrating a conserved role for HIP-family proteins 
facilitating virus infection across evolution. Further validating this conserved pro-viral role, I 
found the human HIP1 inositol phospholipid binding domain could replace the corresponding C. 
86 
 
elegans domain. Going forward, mammalian cell culture offers an excellent reductionist system 
to address more detailed questions about the function of HIP1 and HIP1R in CBV3 infection. 
Methods to address these questions include dissecting the lifecycle stage of CBV3 impacted by 
these HIP proteins. One approach involves determining whether HIP1 or HIP1R affects the early 
stages of the viral lifecyle by transfecting CBV3 genomic RNA into knockout cells and 
evaluating their ability to propogate CBV3. Another approach involves examining whether HIP1 
or HIP1R affects CBV3 entry through virus binding and internalizing assays. The role of these 
proteins should also be investigated in an in vivo mouse infection model to assess any protective 
effects of HIP1, HIP1R, or HIP1/HIP1R double knockouts against CBV3 infection and 
pathogenesis.       
Ultimately, the identification and understanding of novel host factors that enable virus 
infection and propagation can lead to the development of novel antiviral therapies and 
treatments. The expansion of pro-viral factors presented here will enable future studies to better 
understand the relationship and interactions between viruses and their host, in the nascent field of 
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